Evaluating Results of Neusidl Corneal Inserter in Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK)

Status unconfirmed · Phase 4

Conditions studied: Fuchs' Corneal Endothelial Dystrophy

In brief

This project compares the Neusidl Corneal Injector (NCI) device developed by Fischer Surgical, Inc. for the delivery of tissue into the eye in DSAEK surgery to the current standard forceps insertion DSAEK technique. The goal of this study is to examine the damage to the corneal endothelium resulting from the use of the NCI device in comparison to the use of our standard surgical DSAEK technique over time.

Key facts

Study ID

NCT01357122

Run by

Legacy Health System

People needed

100

Starts

2009-07-01

Expected to finish

2015-11-01

Last updated by the study team

2011-05-20

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 21 and over
• A diagnosis of Fuchs' Corneal Endothelial Dystrophy

You may not qualify if…

• Under age 21
• Diagnosis of advanced glaucomatous disease
• Diagnosis of significant retinal disease
• Diagnosis of any other corneal dystrophy
• Previous corneal transplant surgery
• Previous glaucoma surgery
• Previous retinal surgery
• Previous refractive surgery

Where it is running

• Devers Eye Institute — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.